ALD1613, A Novel Long-Acting Monoclonal Antibody to Control ACTH-Driven Pharmacology
Open accessThe DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Abstract
Adrenocorticotropic hormone (ACTH) is the primary regulator of adrenal glucocorticoid production. Elevated levels of ACTH play a critical role in disease progression in several indications, including congenital adrenal hyperplasia and Cushing disease. We have generated a specific, high-affinity, neutralizing monoclonal antibody (ALD1613) to ACTH. In vitro, ALD1613 neutralizes ACTH-induced signaling via all 5 melanocortin receptors and inhibited ACTH-induced cyclic adenosine monophosphate accumulation in a mouse adrenal cell line (Y1). ALD1613 administration to wild-type rats significantly reduced plasma corticosterone levels in a dose-dependent manner. In rodent models with either chronic infusion of ACTH or acute restraint stress-induced ACTH, corticosterone levels were significantly reduced by ALD1613. Administration of ALD1613 to nonhuman primates on days 1 and 7 stably reduced plasma cortisol levels >50% for 57 days. ALD1613 demonstrates the potential of a monoclonal antibody to be an effective therapeutic for conditions with elevated ACTH levels.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Pharmacokinetic–pharmacodynamic studies in rodents and cynomolgus monkeys demonstrated substantial and durable reductions in plasma levels of glucocorticoid134.”
From Management challenges and therapeutic advances in congenital adrenal hyperplasia (2022) · cites this paper as [134]
In the citing paper
“ALD1613 (Alder BioPharmaceuticals, USA) is a specific, high-affinity, long-acting humanized, neutralizing, monoclonal antibody to ACTH that has been tested in preclinical studies134,135.”
From Management challenges and therapeutic advances in congenital adrenal hyperplasia (2022) · cites this paper as [134]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hypothalamic-pituitary-adrenal axis, neuroendocrine factors and stress
Tsigos, C., & Chrousos, G. P. (2002) · Journal of Psychosomatic Research · doi:10.1016/s0022-3999(02)00429-4 · Cited by 2,822
Reshaping human antibodies for therapy
Riechmann, L., Clark, M., Waldmann, H., & Winter, G. (1988) · Nature · doi:10.1038/332323a0 · Cited by 1,562
Restraint stress in biomedical research: A review
Paré, W. P., & Glavin, G. B. (1986) · Neuroscience & Biobehavioral Reviews · doi:10.1016/0149-7634(86)90017-5 · Cited by 376
Circadian rhythm of adrenal glucocorticoid: its regulation and clinical implications
Chung, S., Son, G. H., & Kim, K. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2011.02.003 · Cited by 305
Feelders, R. A., Pulgar, S. J., Kempel, A., & Pereira, A. M. (2012) · European Journal of Endocrinology · doi:10.1530/eje-11-1095 · Cited by 256
Melanocortin receptors: their functions and regulation by physiological agonists and antagonists
Abdel-Malek, Z. A. (2001) · Cellular and Molecular Life Sciences · doi:10.1007/pl00000868 · Cited by 183
Exploring “one-shot” kinetics and small molecule analysis using the ProteOn XPR36 array biosensor
Bravman, T., Bronner, V., Lavie, K., Notcovich, A., Papalia, G. A., & Myszka, D. G. (2006) · Analytical Biochemistry · doi:10.1016/j.ab.2006.08.005 · Cited by 166
Congenital Adrenal Hyperplasia
Witchel, S. F., & Azziz, R. (2011) · Journal of Pediatric and Adolescent Gynecology · doi:10.1016/j.jpag.2010.10.001 · Cited by 161
Merke, D. P., Bornstein, S. R., Avila, N. A., & Chrousos, G. P. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-136-4-200202190-00012 · Cited by 147
The Tissue‐Specific Processing of Pro‐Opiomelanocortin
Bicknell, A. B. (2008) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2008.01709.x · Cited by 135
Evolution of POMC: origin, phylogeny, posttranslational processing, and the melanocortins
Dores, R. M., & Baron, A. J. (2011) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2010.05928.x · Cited by 127
Adrenal Clocks and the Role of Adrenal Hormones in the Regulation of Circadian Physiology
Leliavski, A., Dumbell, R., Ott, V., & Oster, H. (2015) · Journal of Biological Rhythms · doi:10.1177/0748730414553971 · Cited by 118
Neuropeptide Processing and Its Impact on Melanocortin Pathways
Pritchard, L. E., & White, A. (2007) · Endocrinology · doi:10.1210/en.2006-1686 · Cited by 113
Treatment and health outcomes in adults with congenital adrenal hyperplasia
Han, T. S., Walker, B. R., Arlt, W., & Ross, R. J. (2014) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2013.239 · Cited by 102
Comorbidities in Cushing’s disease
Sharma, S. T., Nieman, L. K., & Feelders, R. A. (2015) · Pituitary · doi:10.1007/s11102-015-0645-6 · Cited by 101
Adrenal Splanchnic Innervation Modulates Adrenal Cortical Responses to Dehydration Stress in Rats
Ulrich-Lai, Y. M., & Engeland, W. C. (2002) · Neuroendocrinology · doi:10.1159/000064426 · Cited by 96
Oitate, M., Masubuchi, N., Ito, T., Yabe, Y., Karibe, T., Aoki, T., Murayama, N., Kurihara, A., Okudaira, N., & Izumi, T. (2011) · Drug Metabolism and Pharmacokinetics · doi:10.2133/dmpk.dmpk-11-rg-011 · Cited by 81
Managing Cushing’s disease: the state of the art
Colao, A., Boscaro, M., Ferone, D., & Casanueva, F. F. (2014) · Endocrine · doi:10.1007/s12020-013-0129-2 · Cited by 74
Cooray, S. N., Almiro Do Vale, I., Leung, K.-Y., Webb, T. R., Chapple, J. P., Egertová, M., Cheetham, M. E., Elphick, M. R., & Clark, A. J. L. (2008) · Endocrinology · doi:10.1210/en.2007-1463 · Cited by 73
Kretz, O., Reichardt, H. M., Schütz, G., & Bock, R. (1999) · Brain Research · doi:10.1016/s0006-8993(98)01277-3 · Cited by 73
The next 150 years of congenital adrenal hyperplasia
Turcu, A. F., & Auchus, R. J. (2015) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2015.05.013 · Cited by 70
Congenital Adrenal Hyperplasia Due to 21 Hydroxylase Deficiency: From Birth to Adulthood
Bachega, T., & White, P. (2012) · Seminars in Reproductive Medicine · doi:10.1055/s-0032-1324724 · Cited by 63
Clinical use of pasireotide for Cushing's disease in adults
Boscaro, M., Ceccato, F., & Scaroni, C. M. (2015) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s37314 · Cited by 36
Cushing’s syndrome: an update on current pharmacotherapy and future directions
Creemers, S. G., Hofland, L. J., Lamberts, S. W. J., & Feelders, R. A. (2015) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2015.1061995 · Cited by 31
Medical management of Cushing’s disease
Tritos, N. A., & Biller, B. M. K. (2013) · Journal of Neuro-Oncology · doi:10.1007/s11060-013-1269-1 · Cited by 30
Armario, A., Giralt, M., Martí, O., Gavaldà, A., Hidalgo, J., Hsu, B. R.-S., & Kuhn, R. W. (1994) · Endocrine Research · doi:10.3109/07435809409030405 · Cited by 27
Lightwood, D. J., Carrington, B., Henry, A. J., McKnight, A. J., Crook, K., Cromie, K. D., & Lawson, A. D. G. (2006) · Journal of Immunological Methods · doi:10.1016/j.jim.2006.08.010 · Cited by 26
Giralt, M., García-Marquez, C., & Armario, A. (1987) · Physiology & Behavior · doi:10.1016/0031-9384(87)90202-2 · Cited by 22
The use of mifepristone in the treatment of Cushing's syndrome
Carroll, T. B., & Findling, J. W. (2012) · Drugs of today · doi:10.1358/dot.2012.48.8.1841299 · Cited by 7
Research works printed but not linked: 1
- New M, Lekarev O, Lin-Su K, Parsa A, Khattab A, Pina C, Yuen T, Yau M. Congenital adrenal hyperplasia. In: De Groot LJ, Beck- Peccoz P, Chrousos G, Dungan K, Grossman A, Hershman JM, Koch C, McLachlan R, New M, Rebar R, Singer F, Vinik A, Weickert MO, eds. Endotext. South Dartmouth, MA: MDText. com; 2013. Available from: https://www.ncbi.nlm.nih.gov/books/ NBK278953/?report=classic.
Cited by
Advances in the medical treatment of Cushing's syndrome
Feelders, R. A., Newell-Price, J., Pivonello, R., Nieman, L. K., Hofland, L. J., & Lacroix, A. (2019) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(18)30155-4 · Cited by 154
Involvement of growth factors in diabetes mellitus and its complications: A general review
Shi, G., Shi, G.-R., Zhou, J., Zhang, W., Gao, C., Jiang, Y., Zi, Z., Zhao, H., Yang, Y., & Yu, J. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.02.105 · Cited by 155
Management challenges and therapeutic advances in congenital adrenal hyperplasia
Mallappa, A., & Merke, D. P. (2022) · Nature Reviews Endocrinology · doi:10.1038/s41574-022-00655-w · Cited by 113
A clinical perspective on ectopic Cushing’s syndrome
Ragnarsson, Ó., Juhlin, C. C., Torpy, D. J., & Falhammar, H. (2023) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2023.12.003 · Cited by 95
An individualized approach to the management of Cushing disease
Fleseriu, M., Varlamov, E. V., Hinojosa‐Amaya, J. M., Langlois, F., & Melmed, S. K. (2023) · Nature Reviews Endocrinology · doi:10.1038/s41574-023-00868-7 · Cited by 80
Metadata
- Authors
- Feldhaus, A. L., Anderson, K., Dutzar, B., Ojala, E., McNeill, P. D., Fan, P., Mulligan, J., Marzolf, S., Karasek, C., Scalley-Kim, M., Stewart, E., Billgren, J., Rubin, V., Schneider, K., Jurchen, D., Snow, K., Barnett, S., Bengtsson, B., Baker, B., Latham, J. A., Allison, D., & Garcia-Martinez, L. F.
- Affiliations
- Alder (United States) (US)
- Venue
- Endocrinology
- Publisher
- The Endocrine Society
- Published
- 2016-12
- Volume
- 158
- Issue
- 1
- Pages
- en.2016-1455
- ISSN
- 0013-7227 (ISSN-L)
- 1945-7170
- OpenAlex
- W2558818096
- Cited by
- 32
- References
- 28
- Citations by year
- 2025: 3 · 2024: 7 · 2023: 5 · 2022: 3 · 2021: 1 · 2020: 3 · 2019: 4 · 2018: 5 · 2017: 1
- FWCI
- 3.35
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Endocrinology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal Regulation and Hypertension
- Keywords
- ACTH, neutralizing monoclonal antibodies, melanocortin receptors, corticosterone, cortisol, congenital adrenal hyperplasia, Cushing's disease, restraint stress, non-human primates, glucocorticoid regulation
- MeSH terms
- Adrenal Hyperplasia, Congenital, Adrenocorticotropic Hormone, Animals, Antibodies, Monoclonal, Corticosterone, Cricetulus, Drug Evaluation, Preclinical, Cricetinae, Humans, Hydrocortisone, Macaca fascicularis, Male, Rabbits, Rats, Inbred Lew, Stress, Psychological, CHO Cells, Receptor, Melanocortin, Type 2, Pituitary ACTH Hypersecretion, Rats, Antibodies, Monoclonal, Humanized
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.